News

Apex Partners / News / PE-backed Resonetics to acquire the SASE medical nitinol business

PE-backed Resonetics to acquire the SASE medical nitinol business

January 9, 2023BharbourNews

The deal is valued at $900 million.

The post PE-backed Resonetics to acquire the SASE medical nitinol business appeared first on PE Hub.

Source: https://www.pehub.com/pe-backed-resonetics-to-acquire-the-sase-medical-nitinol-business/

Share this Story

Site Credit: Charlotte Web Design Agency Union

Securities offered through Burch & Company, Inc. member FINRA/SiPC 4151 N Mulberry Drive, Suite 435 Kansas City, MO 64116

Apex Partners and Burch & Company are not affiliated. Any advisory services discussed on this site that are required to be performed by a registered broker-dealer shall be performed by Burch & Company, Inc., through its registered agents, Barry Harbour or Jim McCoy. Apex Partners is not registered as a broker or dealer and therefore does not perform services that involve securities.

News

PE-backed Resonetics to acquire the SASE medical nitinol business

Share this Story

Recent Posts

Categories